Ask a Health Professional: How do semaglutide and tirzepatide support wellness goals?
Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...
Eli Lilly: Still Much Room To Ride The Weight-Loss Wave
Eli Lilly's dominance in the GLP-1 market and strong revenue growth forecast make LLY stock a promising investment, with a ...
Medindia13d
Protecting Muscle and Bone While Taking Weight Loss Medications
Can Ozempic and similar drugs cause muscle and bone loss? Discover how to maintain your health while achieving weight loss ...
Business Insider22d
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
Tirzepatide is the active ingredient ... businesses will still be able to offer some lower-cost medications for weight loss since semaglutide, better known as Wegovy and Ozempic, is still ...
Miami Herald10d
Ask a Health Professional: How do semaglutide and tirzepatide support wellness goals?
As the New Year approaches, many of us feel refreshed and motivated to be our best. Whether you want to adopt a healthier lifestyle, set new fitness goals or just improve overall your well-being ...
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
The U.S. Food and Drug Administration (FDA) recently approved Zepbound® (tirzepatide) as the first prescription medication for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with ...
TCTMD5d
Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
Yahoo22d
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
Patients could face higher costs and tougher access, and telehealth is racing to adapt. The FDA has announced that popular weight loss medication tirzepatide is no longer in shortage, potentially ...
Yahoo News23d
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
Cheaper versions of the drug, known as compounded tirzepatide, might be restricted in 2025. Patients could face higher costs and tougher access, and telehealth is racing to adapt. The FDA has ...